<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_SCUT-China_B_Overview skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:SCUT-China B/Overview</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><P><TITLE>IGEM-China_B</TITLE></P><DIV class="nav"><LI><A href="https://2016.igem.org/Team:SCUT-China_B">Home</A></LI><LI><A href="https://2016.igem.org/Team:SCUT-China_B/Overview">Project</A></LI><LI><A href="https://2016.igem.org/Team:SCUT-China_B/Overview">Overview</A></LI><LI><A href="https://2016.igem.org/Team:SCUT-China_B/Propoptosis">Apoptosis Induction</A></LI><LI><A href="https://2016.igem.org/Team:SCUT-China_B/Protumor">Tumor specific promoter</A></LI><LI><A href="https://2016.igem.org/Team:SCUT-China_B/Results">Achievements</A></LI><LI><A href="https://2016.igem.org/Team:SCUT-China_B/Results">Results</A></LI><LI><A href="https://2016.igem.org/Team:SCUT-China_B/Parts">Parts</A></LI><LI><A href="https://2016.igem.org/Team:SCUT-China_B/Judging">Judging</A></LI><LI><A href="https://2016.igem.org/Team:SCUT-China_B/Modeling">Modeling</A></LI><LI><A href="https://2016.igem.org/Team:SCUT-China_B/Apoptosis">Apoptosis</A></LI><LI><A href="https://2016.igem.org/Team:SCUT-China_B/Crispri">CRISPRi/a</A></LI><LI><A href="https://2016.igem.org/Team:SCUT-China_B/Protocol">Notebook</A></LI><LI><A href="https://2016.igem.org/Team:SCUT-China_B/Protocol">Protocol</A></LI><LI><A href="https://2016.igem.org/Team:SCUT-China_B/Safety">Safety</A></LI><LI><A href="https://2016.igem.org/Team:SCUT-China_B/HP/Gold">Human Practice</A></LI><LI><A href="https://2016.igem.org/Team:SCUT-China_B/HP/Gold">Overview</A></LI><LI><A href="https://2016.igem.org/Team:SCUT-China_B/HP/HP1">Project Design</A></LI><LI><A href="https://2016.igem.org/Team:SCUT-China_B/HP/HP2">Public Outreach</A></LI><LI><A href="https://2016.igem.org/Team:SCUT-China_B/HP/HP3">Hospice Care</A></LI><LI><A href="https://2016.igem.org/Team:SCUT-China_B/Team">Lab</A></LI><LI><A href="https://2016.igem.org/Team:SCUT-China_B/Team">Team</A></LI><LI><A href="https://2016.igem.org/Team:SCUT-China_B/Collaborations">Collaborations</A></LI><LI><A href="https://2016.igem.org/Team:SCUT-China_B/Attributions">Attributions</A></LI></DIV><DIV class="article"><DIV id="non-small"><P class="tit">Non-small cell lung cancer (NSCLC)</P><P class="detail">While Lung cancer is a common kind of cancer, non-small cell lung cancer belongs to lung cancer and takes the percentage of 80%-85% .Unlike most lung cancer , non-small cell cancer usually appears to occur in people who do not smoke.</P><P class="detail">According to the WHO Health statistics [1], the death rate of lung cancer is on the top among cancers. In particular, it is the leading cause of cancer death among males in both developed and undeveloped countries.</P><P class="detail">Figure 1. Death rate among cancers around the world, according to WHO Health statistics.</P></DIV><DIV id="NSCLC"><P class="tit">Therapy for NSCLC</P><P class="detail">Figure 2. According to Nccn clinical practice guidelines in oncology, non-small cell cancer. Current therapy for NSCLC[2], mainly consists of traditional therapy, small-molecule targeted drugs and cancer immunotherapy.</P></DIV><DIV class="btm"><DIV class="click" id="btm1"><A href="https://2016.igem.org/Team:SCUT-China_B/Overview">Overview</A></DIV><DIV class="click" id="btm2"><A href="https://2016.igem.org/Team:SCUT-China_B/Propoptosis">Apoptosis Induction</A></DIV><DIV class="click" id="btm3"><A href="https://2016.igem.org/Team:SCUT-China_B/Protumor">Tumor specific promoter</A></DIV></DIV><DIV class="bar" id="bar"><DIV class="Ltitle"><A href="#non-small">Non-small cell lung cancer (NSCLC)</A></DIV><DIV class="Ltitle"><A href="#NSCLC">Therapy for NSCLC</A></DIV><DIV class="Ltitle"><A href="#">The whole pathway</A></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>